Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Ebb TIDES As Takeda’s Dengue Contender Weaker At 18 Months
Lower DENV-3 Efficacy A Concern?
Nov 26 2019
•
By
Ian Haydock
Takeda Dengue Vaccine Weaker At 18 Months • Source: Shutterstock
More from Clinical Trials
More from R&D